Patients should disclose a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, kidney disease or other dehydration risks, use of diabetes medications such as insulin or sulfonylureas, pregnancy or plans for pregnancy, any personal or family history of medullary thyroid carcinoma or MEN2, and a history of diabetic retinopathy
Questions to consider include Should my bariatric or metabolic surgery team be involved How does my surgical anatomy affect medication tolerance and dosing Are there nutritional risks that need closer monitoring How does this fit into my long term post surgical care plan Clinical guidance from the American Society for Metabolic and Bariatric Surgery emphasizes lifelong multidisciplinary follow up after bariatric surgery, particularly when additional pharmacologic therapies such as Obesity Management Medications are introduced
10.3945/ajcn.2008.26251 [DOI] [PubMed] [Google Scholar] 13.Malaguarnera M, Vacante M, Motta M, Malaguarnera M, Li Volti G, Galvano F
Add a small portion to meals
Medical Dictionary for the Health Professions and Nursing Farlex 2012 melanoma Any benign or malignant tumour of MELANOCYTES
